205 related articles for article (PubMed ID: 9372059)
41. The glycosylphosphatidylinositol anchor and paroxysmal nocturnal haemoglobinuria/aplasia model.
Hall C; Richards SJ; Hillmen P
Acta Haematol; 2002; 108(4):219-30. PubMed ID: 12432218
[TBL] [Abstract][Full Text] [Related]
42. Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria.
Hillmen P; Bessler M; Mason PJ; Watkins WM; Luzzatto L
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5272-6. PubMed ID: 8389477
[TBL] [Abstract][Full Text] [Related]
43. Increased resistance of PIG-A- bone marrow progenitors to tumor necrosis factor a and interferon gamma: possible implications for the in vivo dominance of paroxysmal nocturnal hemoglobinuria clones.
Barcellini W; Fermo E; Guia Imperiali F; Zaninoni A; Bianchi P; Boschetti C; Zanella A
Haematologica; 2004 Jun; 89(6):651-6. PubMed ID: 15194531
[TBL] [Abstract][Full Text] [Related]
44. Paroxysmal nocturnal hemoglobinuria: new insights from murine Pig-a-deficient hematopoiesis.
Devetten MP; Liu JM; Ling V; Weichold FF; Yu J; Medof ME; Young NS; Dunn DE
Proc Assoc Am Physicians; 1997 Mar; 109(2):99-110. PubMed ID: 9069578
[TBL] [Abstract][Full Text] [Related]
45. Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria.
Meletis J; Terpos E
Med Sci Monit; 2003 Jul; 9(7):RA161-72. PubMed ID: 12883466
[TBL] [Abstract][Full Text] [Related]
46. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria.
Brodsky RA; Vala MS; Barber JP; Medof ME; Jones RJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8756-60. PubMed ID: 9238050
[TBL] [Abstract][Full Text] [Related]
47. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.
Araten DJ; Nafa K; Pakdeesuwan K; Luzzatto L
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5209-14. PubMed ID: 10220445
[TBL] [Abstract][Full Text] [Related]
48. CD34+ cells from paroxysmal nocturnal hemoglobinuria (PNH) patients are deficient in surface expression of cellular prion protein (PrPc).
Risitano AM; Holada K; Chen G; Simak J; Vostal JG; Young NS; Maciejewski JP
Exp Hematol; 2003 Jan; 31(1):65-72. PubMed ID: 12543108
[TBL] [Abstract][Full Text] [Related]
49. [Clinical features and diagnosis of paroxysmal nocturnal hemoglobinuria: correlates with the deficiency of GPI-anchored membrane proteins].
Ninomiya H
Rinsho Ketsueki; 1994 Apr; 35(4):352-7. PubMed ID: 7518013
[TBL] [Abstract][Full Text] [Related]
50. Heterogeneity in the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH) syndromes and expansion mechanism of a PNH clone.
Shichishima T; Noji H
Int J Hematol; 2006 Aug; 84(2):97-103. PubMed ID: 16926129
[TBL] [Abstract][Full Text] [Related]
51. Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo.
Chen G; Kirby M; Zeng W; Young NS; Maciejewski JP
Exp Hematol; 2002 Jul; 30(7):774-82. PubMed ID: 12135676
[TBL] [Abstract][Full Text] [Related]
52. PIG-A gene abnormalities in Thai patients with paroxysmal nocturnal hemoglobinuria.
Pramoonjago P; Wanachiwanawin W; Chinprasertsuk S; Pattanapanyasat K; Takeda J; Kinoshita T
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():322-4. PubMed ID: 8629134
[TBL] [Abstract][Full Text] [Related]
53. Paroxysmal nocturnal hemoglobinuria: analysis of the effects of mutant PIG-A on gene expression.
Kanai N; Vreeke TM; Parker CJ
Am J Hematol; 1999 Aug; 61(4):221-31. PubMed ID: 10440907
[TBL] [Abstract][Full Text] [Related]
54. The relationship of aplastic anemia and PNH.
Young NS; Maciejewski JP; Sloand E; Chen G; Zeng W; Risitano A; Miyazato A
Int J Hematol; 2002 Aug; 76 Suppl 2():168-72. PubMed ID: 12430920
[TBL] [Abstract][Full Text] [Related]
55. A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A
Cytometry B Clin Cytom; 2013 Mar; 84(2):71-81. PubMed ID: 23281097
[TBL] [Abstract][Full Text] [Related]
56. New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.
Kawaguchi T; Nakakuma H
Int J Hematol; 2007 Jul; 86(1):27-32. PubMed ID: 17675263
[TBL] [Abstract][Full Text] [Related]
57. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.
Mevorach D
Mol Immunol; 2015 Sep; 67(1):51-5. PubMed ID: 25818314
[TBL] [Abstract][Full Text] [Related]
58. Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice.
Iwamoto N; Kawaguchi T; Horikawa K; Nagakura S; Kagimoto T; Suda T; Takatsuki K; Nakakuma H
Blood; 1996 Jun; 87(12):4944-8. PubMed ID: 8652806
[TBL] [Abstract][Full Text] [Related]
59. [Paroxysmal nocturnal hemoglobinuria].
Wada H; Kanamaru A
Nihon Rinsho; 1996 Sep; 54(9):2507-12. PubMed ID: 8890586
[TBL] [Abstract][Full Text] [Related]
60. Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria.
Chen R; Nagarajan S; Prince GM; Maheshwari U; Terstappen LW; Kaplan DR; Gerson SL; Albert JM; Dunn DE; Lazarus HM; Medof ME
J Clin Invest; 2000 Sep; 106(5):689-96. PubMed ID: 10974022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
